Last update Sept. 4, 2014

Flunisolide

Very Low Risk

Safe. Compatible. Minimal risk for breastfeeding and infant.

Due to a poor systemic absorption, it is unlikely to achieve significant levels in breast milk. Use a minimal dose as possible.
Not commercially available in Spain

Alternatives

We do not have alternatives for Flunisolide since it is relatively safe.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.
DONATE NOW

Group

Flunisolide belongs to this group or family:

Tradenames

Main tradenames from several countries containing Flunisolide in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 21 %
Molecular weight 435 daltons
Tmax 0.5 hours
T½ 1.8 hours

References

  1. National Asthma Education and Prevention Program Asthma and Pregnancy Working Group. Managing asthma during pregnancy: recommendations for pharmacologic treatment-2004 update. 2004;1-57. None 2004 Full text (link to original source) Full text (in our servers)

Total visits

4,430

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM